The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non‐human primate model of Alzheimer's disease
André F. Batista(Universidade Federal do Rio de Janeiro), Fernanda G. De Felice(Universidade Federal do Rio de Janeiro)
Cited by 240
Related Papers
Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models
|Nature Medicine|2018|913
Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
|Frontiers in Cellular Neuroscience|2015|357
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease
|Translational Psychiatry|2021|342
Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseases
|IUBMB Life|2007|334
Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates
|Journal of Neuroscience|2014|227